GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (STU:PMRA) » Definitions » PB Ratio

Pharma Mar (STU:PMRA) PB Ratio : 2.77 (As of May. 05, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharma Mar PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-05), Pharma Mar's share price is €30.50. Pharma Mar's Book Value per Share for the quarter that ended in Mar. 2024 was €11.01. Hence, Pharma Mar's PB Ratio of today is 2.77.

The historical rank and industry rank for Pharma Mar's PB Ratio or its related term are showing as below:

STU:PMRA' s PB Ratio Range Over the Past 10 Years
Min: 2.38   Med: 10.06   Max: 3511.43
Current: 2.83

During the past 13 years, Pharma Mar's highest PB Ratio was 3511.43. The lowest was 2.38. And the median was 10.06.

STU:PMRA's PB Ratio is ranked worse than
55.72% of 1312 companies
in the Biotechnology industry
Industry Median: 2.5 vs STU:PMRA: 2.83

During the past 12 months, Pharma Mar's average Book Value Per Share Growth Rate was -8.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 24.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 81.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 14.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pharma Mar was 171.50% per year. The lowest was -40.00% per year. And the median was -7.10% per year.

Back to Basics: PB Ratio


Pharma Mar PB Ratio Historical Data

The historical data trend for Pharma Mar's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar PB Ratio Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.93 12.78 5.57 5.29 3.87

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 2.56 2.73 3.87 2.61

Competitive Comparison of Pharma Mar's PB Ratio

For the Biotechnology subindustry, Pharma Mar's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's PB Ratio falls into.



Pharma Mar PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pharma Mar's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=30.50/11.005
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pharma Mar  (STU:PMRA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pharma Mar PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Mar's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (STU:PMRA) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (STU:PMRA) Headlines

No Headlines